^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | T Acute Lymphoblastic Leukemia |
| Drug: | cyclophosphamide (Alkylating agent) + etoposide oral (Topoisomerase II inhibitor, DNA inhibitor) + nelarabine (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Acute Lymphoblastic Leukemia: Other Recommended regimens…Nelarabine alone or in combination (eg, nelarabine, etoposide, cyclophosphamide) for T-ALL
